PECAM1 and peripheral arterial disease: Similarly, Delva et al. [132] found that when comparing EPCs isolated from PAD patients and HC, the results varied depending on the EPC subtype, finding a reduction in cEPCs (CD34+, CD34+ CD133+) but an augmentation in ECFCs (CD34+ CD31+ CD144+) in PAD patients versus HC.